Clinical Trial Update: Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607) [Phase 3]

View source ↗

Summary

Phase 3 trial update for SCH 900237/MK-8237 in children and adults with perennial and nonseasonal allergic rhinitis/rhinoconjunctivitis; study completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Rhinoconjunctivitis

Drugs mentioned

• SCH 900237/MK-8237 (SCH 900237/MK-8237)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Nonseasonal | Phase 3 | Status: COMPLETED | Results posted: 2017-03-03